UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016232
Receipt number R000018836
Scientific Title The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care.
Date of disclosure of the study information 2015/02/01
Last modified on 2017/07/19 10:20:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care.

Acronym

The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care.

Scientific Title

The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care.

Scientific Title:Acronym

The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care.

Region

Japan


Condition

Condition

The elderly requiring long-term care

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of leucine enriched jelly for ADL improvement in the elderly requiring long-term care.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

FIM (Functional Independence Measure)

Key secondary outcomes

Nutrition and clinical test data, muscle mass and muscle strength.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Leucine enriched jelly
Period of 12 weeks
Daily dose 100 g
Number-frequency once a day

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Geriatric health services facilities residents.
Aged 65 years and older.
Oral ingestion of universal design Food Category 4 or more is possible.

Key exclusion criteria

Unable to understand the explanation of study.
Leucine enriched jelly intake denial cases.
Apple allergy.
Stage of chronic kidney disease G4, G5 without dialysis.
Vitamin D intake in sum of diet and nutritional supplements is more than 4000IU.
Inappropriate to participate judged by doctors.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidetaka Wakabayashi

Organization

Yokohama City University Medical Center

Division name

Department of Rehabilitation Medicine

Zip code


Address

4-57 Urafune-chou, Minami ward, Yokohama city

TEL

045-261-5656

Email

noventurenoglory@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Yasuko Karibe

Organization

Nursing home Rihab-park Maioka

Division name

Nutrition Division

Zip code


Address

3048-4 Maioka-cho, Totsuka ward, Yokohama city

TEL

045-825-3388

Homepage URL


Email

Karibe-yasuko@shinzen.jp


Sponsor or person

Institute

Nursing home Rihab-park Maioka

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Ajinomoto Co., Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

介護老人保健施設 リハパーク舞岡(神奈川県)
Nursing home Rihab-park Maioka (Kanagawa Prefecture)


Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 12 Month 24 Day

Date of IRB


Anticipated trial start date

2015 Year 02 Month 09 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 16 Day

Last modified on

2017 Year 07 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018836


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name